About this Research Topic
Toxoplasma gondii is one of the most successful parasites; it infects one-third of the human population and most animal species can harbor the parasite. Its complex interaction with host cells enables it to persist for the life of the host. Human Toxoplasma infections have significant public health consequences given the devastating sequelae observed after congenital infections, the visual health impact of ocular infection as a significant cause of blindness, and the destruction caused by disseminated forms in immunosuppressed patients. The advances in genomics, parasite biology and bioinformatics have provided new critical information opening pathways to new drug developments and identification of novel vaccine candidates.
The biennial meeting on Toxoplasma Biology and Toxoplasmosis is the most important event for researchers on Toxoplasma and toxoplasmosis, its XV version was held in Colombia from June 19-22 2019 in Quimbaya, Quindio, Colombia. This was the first occasion that the biennial meeting took place in Latin-America, a region in the world where Toxoplasma is most prevalent and where ocular toxoplasmosis is a leading cause of blindness. During this meeting representatives from almost all laboratories working on this parasite were present.
Preceding the meeting there were two workshops (Environmental Toxoplasmosis and EuPathDB bioinformatic tools course). The meeting included eleven sessions for a total of 66 oral presentations and two poster sessions.
This research topic invites the researchers that presented their work at this meeting to publish in this topic.
This research topic will cover all aspects of the parasite’s biology, its interaction with host cells, and impact and alternatives for the control of the disease.
Keywords: Toxoplasma, Protozoa, Vaccine, Traffic, Intracellular Signaling, Host Parasite Interaction, Biochemistry, Drugs
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.